Log In
BCIQ
Print this Print this
 

SER100 (formerly ZP120)

  Manage Alerts
Collapse Summary General Information
Company Zealand Pharma A/S
DescriptionOpiate receptor-like 1 (OPRL1) partial agonist
Molecular Target Opioid related nociceptin receptor 1 (OPRL1) (NOPR)
Mechanism of ActionORL-1 receptor agonist
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard IndicationHypertension
Indication DetailsTreat isolated systolic hypertension; Treat pulmonary hypertension; Treat treatment resistant isolated systolic hypertension
Regulatory Designation
PartnerSerodus ASA

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today